IOVANCE BIOTHERAPEUTICS, INC. (IOVA) has 7 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 10, 2026 filed Sept. 8, 2026 | Vogt Frederick G Interim CEO & General Counsel | — | +8,988 | +11% | No | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 8, 2026 | BILINSKY IGOR Chief Operating Officer | — | +3,837 | +9% | No | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 8, 2026 | Puri Raj K. Chief Regulatory Officer | — | +5,288 | +10% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Vogt Frederick G Interim CEO & General Counsel | — | +23,967 | +40% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Puri Raj K. Chief Regulatory Officer | — | +2,962 | +37% | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free